🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
BOUNCE is an international multicentre randomised phase II trial. The trial...
Status
Withdrawn
Location
CHU Angers
Start Date
2024-06-07
Trial ID
NCT05718297
Treatments Being Tested
This phase I trial studies the side effects and best dose of brigatinib and...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-02-25
Trial ID
NCT04005144
Treatments Being Tested
The main purpose of the study is to learn about the effectiveness and treat...
Status
Completed
Location
Pfizer Norway
Start Date
2023-06-23
Trial ID
NCT05834348
This study is single arm, open label, phase II trial for resectable ALK+ NS...
Status
Unknown
Location
Yonsei University Health System, Severance Hospital
Start Date
2022-06
Trial ID
NCT05361564
Treatments Being Tested
Phase 1/2, dose escalation and expansion study designed to evaluate the saf...
Status
Recruiting
Location
University of California Irvine Medical Center
Start Date
2022-06-09
Trial ID
NCT05384626
Treatments Being Tested
ROS1 translocated Non small cell lung cancer (NSCLC) is a rare type of lung...
Status
Completed
Location
CHI Créteil
Start Date
2021-03-17
Trial ID
NCT04718012
To estimate the incidence of Early Onset Pulmonary Events (EOPEs), defined ...
Status
Completed
Location
University of Colorado Denver
Start Date
2018-02-22
Trial ID
NCT03389399
The purpose of this study is 2-fold: initially, in the dose escalation phas...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-20
Trial ID
NCT01449461
Treatments Being Tested
This is a study of brigatinib in adults with Non-Small Cell Lung Cancer (NS...
Status
Active Not Recruiting
Location
Dolnoslskie Centrum Onkologii, Pulmonologii i Hematologii
Start Date
2023-05-22
Trial ID
NCT05735327
Treatments Being Tested
This is an open-label, phase I-II dose-escalation and expansion study desig...
Status
Recruiting
Location
Institut Gustave Roussy
Start Date
2022-08-18
Trial ID
NCT04925609
Treatments Being Tested